Now showing items 1-1 of 1
Evaluation of nanoparticles and phages as candidate therapeutic agents for carbapenem resistant Klebsiella pneumoniae and Escherichia coli
(Makerere University, 2022-09)
Centred on the current rate of antibiotics production and approvals, it is anticipated that by 2050 up to 10 million people could die annually due to multidrug-resistant (MDR) pathogens. One of the notable examples of ...